Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update

A Gauthier, M Ho - Hepatology Research, 2013 - Wiley Online Library
Sorafenib is the first and only po administrated drug currently approved to treat advanced
hepatocellular carcinoma (HCC). However, concerns have been raised about sorafenib …
被引用次数：242 相关文章

Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update.

A Gauthier, M Ho - Hepatology Research: the Official Journal of the …, 2012 - europepmc.org
Sorafenib is the first and only orally administered drug currently approved to treat advanced
hepatocellular carcinoma (HCC). However, concerns have been raised about sorafenib …

Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update

A Gauthier, M Ho - Hepatology Research, 2013 - pure.johnshopkins.edu
Sorafenib is the first and only po administrated drug currently approved to treat advanced
hepatocellular carcinoma (HCC). However, concerns have been raised about sorafenib …

[引用][C] Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update

A Gauthier, M Ho - Hepatology Research, 2012 - cir.nii.ac.jp
Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学 …
[PDF] academia.edu

[PDF][PDF] Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update

A Gauthier, M Ho - Hepatology Research, 2012 - academia.edu
Sorafenib is the first and only po administrated drug currently approved to treat advanced
hepatocellular carcinoma (HCC). However, concerns have been raised about sorafenib …
[HTML] nih.gov

[HTML][HTML] The Role of Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma: An Update

A Gauthier, M Ho - Hepatology research: the official journal of the …, 2013 - ncbi.nlm.nih.gov
Sorafenib is the first and only orally administered drug currently approved to treat advanced
hepatocellular carcinoma (HCC). However, concerns have been raised about sorafenib …

Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update

A Gauthier, M Ho - Hepatology Research, 2013 - infona.pl
Sorafenib is the first and only po administrated drug currently approved to treat advanced
hepatocellular carcinoma (HCC). However, concerns have been raised about sorafenib …

Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update

A Gauthier, M Ho - … research: the official journal of the …, 2013 - pubmed.ncbi.nlm.nih.gov
Sorafenib is the first and only po administrated drug currently approved to treat advanced
hepatocellular carcinoma (HCC). However, concerns have been raised about sorafenib …

Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update

A Gauthier, M Ho - Hepatology Research, 2013 - jhu.pure.elsevier.com
Sorafenib is the first and only po administrated drug currently approved to treat advanced
hepatocellular carcinoma (HCC). However, concerns have been raised about sorafenib …

Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update.

A Gauthier, M Ho - Hepatology Research: the Official Journal of the …, 2012 - europepmc.org
Sorafenib is the first and only orally administered drug currently approved to treat advanced
hepatocellular carcinoma (HCC). However, concerns have been raised about sorafenib …